Literature DB >> 24097977

Interaction of Shiga toxin with the A-domains and multimers of von Willebrand Factor.

Nathan C Lo1, Nancy A Turner, Miguel A Cruz, Joel Moake.   

Abstract

Shiga toxin (Stx) produced by enterohemorrhagic Escherichia coli causes diarrhea-associated hemolytic-uremic syndrome (DHUS), a severe renal thrombotic microangiopathy. We investigated the interaction between Stx and von Willebrand Factor (VWF), a multimeric plasma glycoprotein that mediates platelet adhesion, activation, and aggregation. Stx bound to ultra-large VWF (ULVWF) secreted from and anchored to stimulated human umbilical vein endothelial cells, as well as to immobilized VWF-rich human umbilical vein endothelial cell supernatant. This Stx binding was localized to the A1 and A2 domain of VWF monomeric subunits and reduced the rate of ADAMTS-13-mediated cleavage of the Tyr(1605)-Met(1606) peptide bond in the A2 domain. Stx-VWF interaction and the associated delay in ADAMTS-13-mediated cleavage of VWF may contribute to the pathophysiology of DHUS.

Entities:  

Keywords:  Adamts13; Hemolytic Uremia; Platelets; Shiga Toxin; Thrombosis; Toxins; Von Willebrand Factor

Mesh:

Substances:

Year:  2013        PMID: 24097977      PMCID: PMC3829160          DOI: 10.1074/jbc.M113.487413

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Shiga toxin B subunits induce VWF secretion by human endothelial cells and thrombotic microangiopathy in ADAMTS13-deficient mice.

Authors:  Jing Huang; David G Motto; David R Bundle; J Evan Sadler
Journal:  Blood       Date:  2010-07-19       Impact factor: 22.113

2.  Shiga toxin (Stx)1B and Stx2B induce von Willebrand factor secretion from human umbilical vein endothelial cells through different signaling pathways.

Authors:  Fang Liu; Jing Huang; J Evan Sadler
Journal:  Blood       Date:  2011-08-03       Impact factor: 22.113

3.  FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay.

Authors:  Koichi Kokame; Yuko Nobe; Yoshihiro Kokubo; Akira Okayama; Toshiyuki Miyata
Journal:  Br J Haematol       Date:  2005-04       Impact factor: 6.998

4.  Conformational stability and domain unfolding of the Von Willebrand factor A domains.

Authors:  Matthew Auton; Miguel A Cruz; Joel Moake
Journal:  J Mol Biol       Date:  2006-10-25       Impact factor: 5.469

5.  In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology.

Authors:  Michelle Tsai; Ashley Kita; Joseph Leach; Ross Rounsevell; James N Huang; Joel Moake; Russell E Ware; Daniel A Fletcher; Wilbur A Lam
Journal:  J Clin Invest       Date:  2011-12-12       Impact factor: 14.808

Review 6.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.

Authors:  Phillip I Tarr; Carrie A Gordon; Wayne L Chandler
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

7.  The interaction of von Willebrand factor-A1 domain with collagen: mutation G1324S (type 2M von Willebrand disease) impairs the conformational change in A1 domain induced by collagen.

Authors:  L D Morales; C Martin; M A Cruz
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

8.  Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibalpha.

Authors:  C Martin; L D Morales; M A Cruz
Journal:  J Thromb Haemost       Date:  2007-03-27       Impact factor: 5.824

9.  Destabilization of the A1 domain in von Willebrand factor dissociates the A1A2A3 tri-domain and provokes spontaneous binding to glycoprotein Ibalpha and platelet activation under shear stress.

Authors:  Matthew Auton; Katie E Sowa; Scott M Smith; Erik Sedlák; K Vinod Vijayan; Miguel A Cruz
Journal:  J Biol Chem       Date:  2010-05-24       Impact factor: 5.157

Review 10.  AB toxins: a paradigm switch from deadly to desirable.

Authors:  Oludare Odumosu; Dequina Nicholas; Hiroshi Yano; William Langridge
Journal:  Toxins (Basel)       Date:  2010-06-25       Impact factor: 4.546

View more
  4 in total

1.  Cytotoxic activity and degradation patterns of structural proteins by corneal isolates of Acanthamoeba spp.

Authors:  Viviane Peracini Sant'ana; Linda Christian Carrijo-Carvalho; Annette Silva Foronda; Ana Marisa Chudzinski-Tavassi; Denise de Freitas; Fábio Ramos Souza de Carvalho
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-08-27       Impact factor: 3.117

Review 2.  Hemolytic uremic syndrome.

Authors:  Caterina Mele; Giuseppe Remuzzi; Marina Noris
Journal:  Semin Immunopathol       Date:  2014-02-14       Impact factor: 9.623

3.  Decreased severity of Shiga toxin-producing Escherichia coli haemolytic uraemic syndrome (STEC-HUS) in a child with type 1 von Willebrand disease.

Authors:  Matthew A Geramita; Johannes Hofer; James Cooper; Michael L Moritz
Journal:  BMJ Case Rep       Date:  2017-08-30

Review 4.  COVID-19 microthrombosis: unusually large VWF multimers are a platform for activation of the alternative complement pathway under cytokine storm.

Authors:  Yoshihiro Fujimura; Linda Z Holland
Journal:  Int J Hematol       Date:  2022-03-22       Impact factor: 2.319

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.